Trial Profile
A Randomized Single Dose Crossover Comparison of the Safety, Tolerability, and Pharmacokinetic Profile of CTP-692 Versus D-Serine
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 04 Nov 2021
Price :
$35
*
At a glance
- Drugs Deutarserine (Primary) ; D-serine
- Indications Schizophrenia
- Focus Adverse reactions; Pharmacokinetics
- Sponsors Concert Pharmaceuticals
- 12 Jun 2019 According to a Concert Pharmaceuticals media release, data from this tria was presented as a poster at the 2019 American Society of Clinical Psychopharmacology Annual Meeting in Scottsdale, AZ.
- 12 Jun 2019 Results published in the Concert Pharmaceuticals Media Release
- 02 May 2019 According to a Concert Pharmaceuticals media release, results will be presented during the poster session at The American Society of Clinical Psychopharmacology (ASCP) annual meeting May 28-31, 2019.